Drug Trial Radar · NCT01805856
Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
Last checked: Nov 20, 2026Latest source record: Mar 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,164
Actual
Start
Nov 2010
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Ito HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 6, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 10 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The effectiveness of antimicrobial prophylaxis (AMP) for prevention of surgical site infection (SSI) following thyroid and parathyroid surgery remains uncertain. Present prospective randomized control study (Ito-RCT1) assessed the effectiveness of AMP in clean neck surgery associated with thyroid and parathyroid disease.
Conditions
- Thyroid Disease
- Parathyroid Disease
Interventions
PIPC piperacillin sodiumDrug
CEZ, cefazolin sodiumDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical site infections after thyroid and parathyroid surgeryTime frame: 1 month after operation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ito Hospital
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.